TARA generates human relevant data to enable faster, safer, and more accurate development of new treatments. Our platform can reduce cost and increase the success of important new medicines reaching patients.
Cardiac Drug Discovery
We generate disease models from stem cells, enabling discovery of new medicines for heart conditions.
Cardiac Safety
Our cardiac tissue models reliably represent adult human hearts when applied to drug testing. We can accurately identify cardiovascular complications.
Precision Cardiology
Our platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment.
NEW YORK, NY - (EurekAlert) - VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration for accelerated cardiac drug development. The partnership will leverage TARA’s…
READ MORENEW YORK, NY - (EurekAlert) - TARA Biosystems today reported study results demonstrating the ability of TARA’s in vitro human cardiac models to reproduce drug responses similar to those observed…
READ MORENEW YORK, NY - (BUSINESS WIRE) - TARA Biosystems, Inc., a company generating in vitro human biology to increase the success of cardiac disease drug discovery and development, today…
READ MORE
